Chronic shipbuilding execution misses (labor, throughput) at 5% margins — one bad program can erase a year of EPS
One-line thesis. HII owns an essentially unassailable monopoly building America's aircraft carriers and submarines with a $54B backlog (>4× annual revenue), but the business runs at ~5% operating margins, guides to only ~6% revenue growth, carries 2.3× net-debt/EBITDA, and has burned through a 36% drawdown on repeated labor/throughput misses — so the "moat" and the mediocre economics are both true at once. Cheap, safe-ish, but not a compounder: Watch.
◆ Synthos call — HoldHII is a solid business largely reflected at ~$330 — fine to keep, no reason to chase; it gets interesting again below ~$280.
Downside Risk (lower = safer)
5/10 · Moderate
Low beta (0.23) & 54B backlog cushion, but 2.3x net-debt/EBITDA, thin 5% margins, chronic execution misses and a 36% drawdown.
Growth Quality
5/10 · Moderate
~12% forward EPS CAGR off a low base, but 5% margins, single-customer (US Navy) concentration and mid-single-digit revenue guidance.
Exponential Potential
3/10 · Low
A monopoly-scale build backlog but capacity-constrained, decelerating and mature — mid-single-digit revenue growth caps any multibagger.
⚖ Reverse-DCF cross-checkMarket-implied growth ≈ 3%/yrTo justify today’s $292, earnings would have to compound roughly 3% a year for 10 years (9% discount rate). Analysts forecast ~5%/yr, so the market is pricing in LESS than what the Street expects.What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.
In plain English
Huntington Ingalls is the company that literally builds the U.S. Navy's aircraft carriers and nuclear submarines — there is essentially one other yard in the country that can do this, so its position is about as protected as a business gets. It has $54 billion of work already booked (more than four years of sales), so it will not run out of orders.
The problem: building giant warships is a brutally low-margin, labor-heavy business. HII keeps only about 5 cents of operating profit per sales dollar, it has repeatedly missed its own targets because it can't hire and train welders fast enough, and the stock has fallen about 36% from its high. It's cheap now — but cheap because the profits have been disappointing.
Our verdict is Watch: a solid, safe-feeling business that is not growing fast and keeps stubbing its toe on execution. Worth owning only if you specifically want a cheap, defensive, recovery bet — not a growth stock.
Here's what our three scores mean in everyday terms:
Downside Risk 5/10 (middle). The stock barely moves with the market (very low beta) and the backlog is a huge safety net — but it carries meaningful debt and thin margins, so a single bad ship program hurts.
Growth Quality 5/10 (average). Growth is slow and steady, not exciting; the profits are thin and depend almost entirely on one customer, the U.S. government.
Exponential Potential 3/10 (low). This is a mature monopoly that can only build ships so fast. Don't expect it to multiply — expect a slow, steady grind.
The one big worry: HII's whole story is execution. At 5% margins, it doesn't take much — a labor shortage, a delayed carrier, a bad contract — to wipe out a year's worth of profit.
Note on expert coverage: no outside expert in the Synthos knowledge base has published a view on HII. This report is built entirely from the company's own financials and quantitative data — not from analyst conviction.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Relative performance vs S&P 500 & its sector (XLI (sector)), set to 100 a year ago
Solid = HII · dashed = S&P 500 · dotted = XLI (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
Price$291.50
Market cap$11B
P/E trailing13×
P/E FY26E / FY27E17× / 14×
EV / Sales1.1×
EV / EBITDA11.8×
Gross margin12.4%
Net margin4.7%
Dividend yield1.88%
Beta0.232
52-wk range$248 – $454
RSI(14)42
50 / 200-DMA$315 / $347
12-mo return+18% (SPY +21%)
Street target$420 ($419–$421)
Analyst grades12 Buy · 14 Hold · 1 Sell
FMP ratingB+
Next earnings2026-08-05
What the experts actually said 0 traceable claims on HII · showing the highest-conviction voices
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
1. What it is
Huntington Ingalls Industries (NYSE: HII) is the largest independent military shipbuilder in the United States, founded 1886, spun out of Northrop Grumman in 2011, headquartered in Newport News, Virginia, with ~44,000 employees. It designs, builds, modernizes and maintains military vessels across three segments, and its customer is overwhelmingly the U.S. Navy and U.S. Coast Guard. Fiscal year ends December 31.
Revenue mix — by segment (FY2025, from filings):
Newport News Shipbuilding — $6.51B (52%): nuclear-powered aircraft carriers and submarines (Virginia- and Columbia-class), plus refueling/overhaul and naval nuclear support. This is the crown jewel — a genuine national monopoly.
(Segment figures sum to $12.63B of gross segment revenue vs $12.48B consolidated, the difference being intersegment eliminations.)Geographic split: FMP provides no geographic segmentation, but the business is ~all-U.S.-government — a concentration that is simultaneously the moat (assured demand) and the single biggest structural risk (one customer, budget-dependent).
The strategic reality: HII is a capacity-constrained monopoly. Demand (backlog $54B) is not the constraint — the ability to hire, train and retain shipyard labor and push throughput through fixed physical yards is. That is exactly what management has repeatedly missed on.
2. The expert thesis — (no coverage)
There is no expert coverage of HII in the Synthos knowledge base. total_claims = 0; net-bullish voices = 0. No independent analyst, fund manager, or podcast voice we track has published a signed, traceable view on this name.
That is an honest and important admission: this verdict carries no conviction premium. It is built entirely from (a) the company's reported financials, (b) live FMP analyst consensus estimates, and (c) our own quant framework. Where a conviction name like our flagship pharma would cite a dozen reconciled claim_ids, HII cites none — because there are none to cite. Do not read the "Watch" as a hedged bull case backed by experts; read it as a purely fundamentals-and-quant read on a cheap, slow, well-protected monopoly with a chronic execution problem.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
Score
0–10
The read
Downside Risk(lower = safer)
5 · Moderate
Beta 0.23 (barely moves) and a $54B backlog are real cushions; but 2.3× net-debt/EBITDA, ~5% operating margins, and a −36% drawdown on execution misses keep this from being "safe."
Growth Quality
5 · Average
~12% forward EPS CAGR — but that's margin recovery off a depressed 2025, on ~6% guided revenue growth, thin 5% margins, ROIC ~5%, single-customer concentration. Durable, not high-quality.
Exponential Potential
3 · Low
Monopoly demand, but physically capacity-constrained and decelerating to mid-single-digit revenue. No multibagger path; a slow compounder at best.
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is the expected path, so a weighted blend would just restate it with false precision. The cases bound the range; the scores above summarize them.
Case
Key assumptions
Fair value
Bull
Shipbuilding throughput/labor normalizes; margins recover toward 7–8%; defense-budget tailwind (submarine ramp) accelerates. FY27E EPS beats to ~$22 (vs $20.1 cons); re-rates to a defense-quality ~19–20×.
~$430 (+48%)
Base(our anchor)
Estimates roughly hit — FY27E EPS ~$20.1; margins recover slowly; a low-growth monopoly earns a ~16.5× multiple.
~$330 (+13%)
Bear
Labor/throughput misses persist; a fixed-price program takes a charge; margins stall near 5%. FY27E EPS misses to ~$16.5; de-rates to ~13.5×.
~$225 (−23%)
Synthos fair value = the base case, ~$330 (+13%), with the full $225–$430 span as the honest range. Note our base sits well below the Street's $420 consensus — the sell-side is effectively pricing the bull (full margin recovery), and we are not willing to underwrite that at 5% margins with a multi-year miss track record. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating multi-baggers-from-here). HII is neither an exponential nor even a high-quality compounder — it is a low-growth, capacity-constrained monopoly:
Forward growth: revenue CAGR FY25→FY30E ~5.2% ($12.48B → $16.08B); management explicitly guides medium-term revenue growth of ~6%. EPS CAGR is higher at ~12.2% ($15.39 → $27.39) — but that is margin recovery off a depressed 2025 net margin (4.7%), not demand acceleration.
Acceleration (2nd derivative): revenue growth was +8.2% (FY25) decelerating toward the guided ~6% — the top line is flat-to-decelerating, and the constraint is physical yard capacity, not order book. There is no inflection here.
Room to run: demand is effectively unlimited (US Navy, $54B backlog) — but that is not the binding constraint. HII cannot simply build more ships faster; the yards, drydocks and skilled-labor pool are fixed. A monopoly on a slow-growing, capacity-capped market is safe, not exponential.
Reinvestment runway: capex is ~4–5% of sales into fixed shipyard infrastructure — necessary maintenance/expansion, not a high-ROIC growth flywheel (ROIC ~5%).
Exponential Potential: Low (3/10). Own HII, if at all, for defensive stability and a cheap multiple — not for growth. A small, accelerating name would score 8–9 here; a decelerating $11B monopoly earning 5% margins scores a 3.
Margins (the core problem): gross 12.4% TTM, operating ~4.9% TTM, net 4.7% TTM. Shipbuilding is structurally low-margin and HII has been at the low end of its own range on execution. FY25 operating income $608M on $12.48B revenue.
Earnings: net income $605M FY25 (+10% on FY24 $550M), EPS $15.39 (vs $13.96). But note the multi-year round-trip: EPS was $17.14 back in FY20 — five years of no EPS growth until the recent recovery.
Cash flow: FY25 operating CF $1.20B, capex −$402M, FCF $794M (FCF yield ~9% on today's cap). But cash flow is lumpy and back-half-weighted — Q1'26 FCF was negative $461M (normal seasonality for this business; management guides FY26 FCF to $500–600M).
Balance sheet: total debt $3.15B, cash $774M, net debt $2.37B → net-debt/EBITDA 2.26×. Investment-grade and serviceable (interest coverage ~6×), but not a fortress — this is meaningful leverage for a thin-margin cyclical.
Backlog:$54.0B as of Q1'26 (>4× annual revenue) — the single best feature of the financials: multi-year demand visibility.
6. Valuation — cheap, but cheap for a reason
On the surface HII looks inexpensive: 18.9× trailing EPS, 1.1× EV/sales, 11.8× EV/EBITDA, ~9% FCF yield, 1.9% dividend. On forward estimates it gets cheaper as margins recover: 16.8× FY26E → 14.5× FY27E → 10.6× FY30E. A reverse read: at $291 the market is pricing persistent thin margins and mid-single-digit growth — i.e. it is not pricing the margin recovery the Street bakes in.
The honest caveat: cheap multiples on thin, execution-dependent margins are a value trap risk. A defense monopoly deserves a defense multiple (~16–18×) only if it delivers defense-quality margins and reliability — HII has not, hence the discount to peers and the −36% drawdown. Street targets (context): consensus $420 (high $421 / low $419) — a tight, high cluster that effectively underwrites full margin recovery. Our base ($330) is deliberately below it because we weight the miss track record more heavily. Not a value bargain; a cheap monopoly with an execution overhang.
7. Technicals (from the tech block)
Trend:down. $291.50 sits below the 50-DMA ($314.54) and 200-DMA ($346.63), and the 50 is below the 200 (death-cross posture). MACD −9.8 (negative).
Location:−35.8% off the 52-week high ($453.73), only +17.6% off the 52-week low ($247.95) — deep in a drawdown, near the lower third of its range. Max drawdown from peak −35.8%.
Momentum: RSI(14) 42 — below neutral, weak but not yet oversold (<30), so no capitulation-bounce signal.
Relative strength (the tell): HII −25.9% 3-mo vs SPY +13.7% / QQQ +22.0%, and −14.8% 6-mo vs SPY +8.4%. It is badly lagging the market and its own sector — persistent underperformance, not a coiled spring.
Read: technicals do not confirm a bottom. This is a falling knife in a clear downtrend; the low beta (0.23) means it won't rip up with the market either. No technical urgency to buy — a stabilization above the 50-DMA (~$315) with improving relative strength would be the first constructive sign.
8. Moat & competitive position
HII's moat is genuinely one of the widest in the S&P 500 — and also one of the most capped. Newport News is one of only two U.S. shipyards (with General Dynamics' Electric Boat) capable of building nuclear-powered submarines, and the only yard building nuclear aircraft carriers. The barriers — capital, security clearance, a nuclear-qualified workforce, decades of accumulated know-how — are effectively insurmountable. Switching cost for the customer is infinite; the Navy cannot go anywhere else.
The flip side: a monopoly on a fixed-price, single-buyer, capacity-constrained business. HII cannot raise prices freely (the Navy negotiates hard, often fixed-price), cannot grow faster than its yards allow, and absorbs cost-overrun and labor risk. The moat guarantees survival and demand, not high returns.
Peer set (FMP-supplied, market cap): the list — Avery Dennison $12.8B, TopBuild $9.9B, Builders FirstSource $9.1B, Leonardo DRS $11.7B, Embraer $11.8B, Karman $7.5B, Lincoln Electric $14.2B, Stantec $8.0B, Textron $16.1B, Wesco $15.0B — is a loose market-cap-based industrial basket, not a true comp set. The only genuine defense peers here are Leonardo DRS and Textron. The truly relevant comp is unlisted: General Dynamics (Electric Boat, the submarine co-builder). Against pure-play defense primes, HII carries the lowest margins and the biggest execution discount.
9. Management, capital allocation & guidance
Capital allocation: dividend-first (1.9% yield, ~35% payout), modest buybacks paused in FY25, and steady ~4–5%-of-sales capex into yard capacity. Debt reduction (paid down $500M in FY25). Reasonable and conservative for a leveraged cyclical, but not value-additive at ~5% ROIC.
Insider activity: the only recent Form 4s (all 2026-07-01) are routine director stock awards (174 shares each at $278.97) — standard board compensation, no open-market buying or selling signal in the sampled window.
Management's own guidance (half-weighted — their own book): HII's Q1'26 earnings release (SEC 8-K, filed 2026-05-05) reaffirmed FY26 and medium-term guidance. In management's own words: FY26 shipbuilding revenue $9.7–9.9B at 5.5–6.5% operating margin; Mission Technologies revenue $3.0–3.2B at ~5% segment margin; FY26 free cash flow $500–600M; effective tax rate ~17%; capex 4–5% of sales. Medium-term: ~6% total revenue growth (~6% shipbuilding, ~5% Mission Technologies). CEO Chris Kastner emphasized improving shipbuilding throughput and expanding the industrial base. Treat as management's self-interested framing (half-weight); notably the ~5–6.5% margin guidance corroborates the thin-margin thesis rather than contradicting it.
10. Catalysts & what to watch
Next earnings: 2026-07-30 (Q2'26; Street EPS $3.84, revenue ~$3.15B). Key line: shipbuilding operating margin — is throughput improvement translating to margin, or being eaten by labor cost?
Free cash flow ramp: HII's FCF is heavily back-half-weighted; watch whether it's tracking to the $500–600M FY26 guide (Q1 was −$461M by design).
Labor & throughput: the new Ingalls collective-bargaining agreement (ratified, extends to 2031) removes one labor risk; watch Newport News hiring/retention and carrier/submarine schedule adherence.
Defense budget / submarine ramp: the Columbia- and Virginia-class submarine build rate and any AUKUS-related demand are the real medium-term swing factors.
Contract awards & backlog: $54B backlog is the anchor; watch for new carrier/submarine block-buy awards.
Thesis tripwires (what would change the call): a fixed-price program charge; shipbuilding margin slipping below 5%; FCF missing the $500–600M guide; or net-debt/EBITDA rising above ~2.5×. Conversely, two clean quarters of margin recovery toward 7% would move this from Watch toward Buy.
11. Key risks
Execution / margin risk (structural, #1): at ~5% operating margins, a single labor shortage, throughput miss, or fixed-price cost overrun can erase a year of EPS. This is the recurring reason for the −36% drawdown.
Single-customer concentration: ~all revenue is U.S.-government — exposed to defense-budget cycles, continuing resolutions, and program cancellations. Assured demand, but zero pricing diversification.
Leverage: 2.3× net-debt/EBITDA on a thin-margin cyclical is not trivial; leaves less cushion for a bad program.
Capacity ceiling: the moat is real but caps growth — HII physically cannot scale output quickly, so it can't grow into its multiple through volume.
Valuation is a trap risk: "cheap" on depressed margins can stay cheap or get cheaper if margins don't recover — the −26% 3-month underperformance shows the market's skepticism.
No expert corroboration: with zero KB coverage, there is no independent conviction check on this call — it rests solely on quant/fundamentals.
12. Verdict, position sizing & monitoring
Watch. HII is a genuinely rare asset — a national-security monopoly building America's carriers and submarines with a $54B backlog and a stock that barely moves with the market. But the economics are mediocre (5% margins, ~5% ROIC), growth is slow (~6% guided), leverage is real (2.3×), and the company has a multi-year record of missing on execution — capped by a 36% drawdown and a clear downtrend. It is cheap (16.8× FY26E, 9% FCF yield), but cheap for identifiable reasons. This does not clear the bar for a Buy, and there is no expert conviction to lean on. It is a legitimate Watch — and a candidate to upgrade if margins visibly recover.
Sizing: if entered at all, a value/defensive satellite ≤2–3% — a cheap, low-beta recovery bet, not a core compounder. Given the downtrend, there is no urgency; wait for a margin-recovery print or a stabilization above the 50-DMA.
Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $291.50.
Single biggest risk: chronic shipbuilding execution misses at 5% margins — the whole recovery thesis is an execution bet.
Provenance & disclosures
Traceability:0 KB claims, breadth 0 — HII has no expert coverage in the Synthos knowledge base. This verdict is explicitly fundamentals- and quant-driven, with no conviction premium. Fabricated conviction is structurally impossible (claim-ID reconciliation), and here there are simply no claims to cite.
Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · management guidance from the SEC 8-K earnings release filed 2026-05-05. Forward figures are analyst consensus (FMP) or management guidance, each labeled as estimates.
Management caveat: HII's reaffirmed FY26 guidance is management's own book, half-weighted by design; notably it corroborates (not contradicts) the thin-margin thesis.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").